After being fired, I became the light of medicine

Chapter 239 We must use Zhang Yang’s weaknesses to please him!
In addition to professional doctors like Dr. Richard, the news of "Ibetumumab" has undoubtedly aroused strong attention among leukemia patient groups abroad.

Just like in China, leukemia patients abroad also communicate through chat software like WeChat.

However, compared to professional doctors who still have some doubts about the authenticity of "Ivacuzumab", patients do not have so many thoughts. They were instantly excited when they saw the news that "Ivacuzumab" can treat acute leukemia.

"Shit, Shit! Finally there is a targeted drug that can treat 'acute myeloid leukemia'. I love Qingshan Pharmaceutical so much!"

"Hahahaha, me too. This is really the best news I've heard this year. We finally have hope! Like I said before, if we want to treat leukemia, we have to rely on China's Qingshan Pharmaceutical. Our pharmaceutical companies are all shit!"

"I absolutely agree with you. Whether it's Pfizer or Novartis, their research and development focus is on more profitable chronic diseases. How many years have we not seen a new leukemia drug? Those pharmaceutical companies don't care about our life or death at all!"

"Yes, so in the field of blood diseases, the only one we can rely on now is Qingshan Pharmaceutical!"

"Well...I am really grateful to Qingshan Pharmaceutical."

The group was talking enthusiastically that thanks to the good reputation of "ITG Human Myelopoietin" among patients with blood diseases, all patients have an inexplicable trust in Qingshan Pharmaceutical.

However, after the excitement, many patients gradually calmed down and began to understand more detailed information.

"@David, you are well-informed. Do you know more about this targeted drug? For example, they are now conducting clinical trials. How is the trial going?"

David is the leader of the patient group and the president of the Leukemia Union Alliance.

At the same time, he himself is also a patient with chronic myeloid leukemia.

"Sorry, I saw this news on the news just like everyone else, so I don't know the details."

"But... I will pay special attention to this matter next. Although I don't speak Chinese, translation software is very popular now. I plan to go to the official website of Qingshan Pharmaceutical. Their website should update the clinical data in real time!

Also, there should be Chinese forums related to leukemia in China. I will also go to the Chinese forums to read the real feedback from patients! "

"That's great, thank you David for your hard work! But... I suddenly envy the leukemia patients in China!"

This message suddenly appeared in the patient group, and the group that was originally discussing excitedly suddenly paused for two seconds.

After a while, more news appeared.

"Sure! Who wouldn't be envious? Chinese patients can receive the best and newest drugs in the world for treatment at the first opportunity, and can also easily obtain a large amount of relevant information. What about us?! Not to mention treatment, even the information we get is second-hand!"

"Fuck! There's nothing we can do about it. The previous 'ITG Myelopoietin' was like that. We reluctantly introduced it to China more than a year after it was already on the market!

You know, we were the first to receive the latest drugs before. For example, many years ago, we had been on the first-line treatment plan for 'Avatrombopag Tablets' for two or three years, but the Chinese market had not yet introduced it, and was still using the most backward drugs from the 1980s!"

"Now the situation is completely reversed. The top-notch drugs are almost always used by Chinese people first. We have become second-class humans!"

“Oh… let’s not talk about this anymore. I just hope that this targeted drug from Qingshan Pharmaceutical really has the therapeutic effect they say, and can be introduced to Europe as soon as possible!
Also, my biggest wish is that the price of the product can be cheaper!"

When it comes to price, the discussion in the group instantly shifted from clinical trials to price.

This is undoubtedly a topic that everyone is concerned about!
But soon, everyone suddenly thought of "ITG human myelopoietin"...

"No, it's impossible! Have you forgotten the huge price difference between Europe and China for 'ITG Myelopoietin' that was exposed a few years ago?!"

"10 injections of 'ITG myelopoietin' will cure China for only 3.5 yuan, which is equivalent to 4000 pounds! In our country, just one injection costs 5000 pounds!"

"This is a unique treatment for Chinese patients. Their fees are the lowest in the world. We can't possibly enjoy it!"

The group suddenly fell silent, and after a while:
"Fuck! I really want to be a Chinese! Their medical treatment and medical benefits are much better than ours!"

"That's right! I want to immigrate. I want to live in China!"

"No, we can't immigrate. China's green card is the most difficult to get in the world, much harder than the United States! Our best way is to live in China for a short period of time and receive treatment!"

"Yes, yes, yes! David, please pay special attention to the clinical news of 'Ibeumab'. Once the effect is good, I will go to China for treatment!"

"OK!"

Similar conversations are happening not just among leukemia patients in Europe.

In America, Australia, and even Central Asia, all groups of blood disease patients with some source of information began to discuss the topic of "Iveluzumab" enthusiastically, and all leukemia patients were excited!

That's right!

Even though the clinical trial results of "Ivacuzumab" are still unclear and the final pricing of the drug has made countless patients nervous, Tsingshan Pharmaceutical has relied on the brand influence accumulated over the years. The emergence of "Ivacuzumab" has brought hope of life to all leukemia patients around the world!

It’s like a bright light suddenly lit up in the darkness!
Although small and out of reach, this is hope!

At this moment, Tsingshan Pharmaceutical suddenly became a beacon for all leukemia patients around the world!
Countless patients are looking forward to it. On the other hand, GlaxoSmithKline's UK headquarters, which has a good cooperative relationship with Tsingshan Pharmaceutical, has also noticed the news about "Ibeumab".

GlaxoSmithKline headquarters, London, UK.

The first collaboration between GlaxoSmithKline and Tsingshan Pharmaceutical originated from "ITG Human Myelopoietin". Subsequent research and development of drugs such as "Hepatocyte Activator" and "Kidney Toxin Clearing Dialysis Needle" were also introduced by GlaxoSmithKline to the UK and even the European continent.

Therefore, as one of the world's top pharmaceutical companies, GlaxoSmithKline actually has a very good relationship with Tsingshan Pharmaceutical.

In particular, their vice president Lucas and Zhang Yang have a good personal relationship.

"Lucas, Qingshan Pharmaceutical has developed a targeted drug for the treatment of 'acute leukemia' - Ibelumab has begun clinical trials. Have you noticed this news?!"

In the office, early in the morning, President William called Lucas.

"Of course, President William, I saw the relevant reports last night."

"I was just about to report this to you!"

"Oh?"

William, president of GlaxoSmithKline, is a typical British elite man, wearing an exquisite simple watch on his wrist and polished Oxford shoes on his feet.

After hearing Lucas's answer, he took a sip of coffee and said:
"So tell me what you think of this news? Do you think their clinical trial will be successful?"

"Yes, definitely."

Lucas answered firmly without any hesitation. After that, he sat down on the sofa in the office with a little caution and continued:
"We have been working with Qingshan Pharmaceutical for so many years. Their R&D capabilities... I wouldn't be surprised at what kind of drugs they develop!"

"So... President William, we think we should pay close attention to this matter. Once their clinical data is in line with expectations, we should contact Qingshan Pharmaceutical as soon as possible and apply for cooperation."

"Exactly what I thought!"

Hearing Lucas' unhesitating trust in Qingshan Pharmaceutical, President William not only did not think there was anything wrong with it, but nodded in agreement.

He took another sip of coffee and said slowly:
"So, I called you here today because I hope Lucas... you go to China right now and negotiate with Qingshan Pharmaceutical for the exclusive European agency rights for this drug!"

"Go now?!"

Lucas was stunned for a moment. He originally thought that his attitude towards Tsingshan Pharmaceutical was already "radical". After all, Tsingshan Pharmaceutical had just started Phase I and Phase II clinical trials, and even the clinical data of the first batch of patients had not come out yet, so he had no idea whether it was good or bad!

But I didn't expect that President William, who has always been conservative, would suddenly become more radical than me?
This is conservatives thinking radicals are too conservative?!

"President William... going now? Wouldn't that be too radical?"

"After all... although I have great confidence in Qingshan Pharmaceutical, it would be too rash to discuss cooperation involving real money! "

"will not!"

President William shook his head. After a moment, he suddenly crossed his legs and said:

"I did a simple statistical analysis last night. There are about 16 new cases of acute myeloid leukemia worldwide each year, and about 3.5 cases in Europe each year."

"As for the number of existing 'acute myeloid leukemia' patients...due to the high five-year mortality rate of acute leukemia, the current number of existing patients is about 15."

"If Qingshan Pharmaceutical's 'Ibetumumab' can really achieve an 80% therapeutic effect and can really be taken as a first-line treatment drug for a long time, then even if each patient only spends 10 pounds a year, our annual sales of this drug will reach more than 180 billion pounds, and the profit... can also reach at least 30 billion!"

"Moreover, after long-term use, the number of people taking the drug will increase year by year, just like Novartis' Gleevec!"

"So! We can't give up such a huge profit. We must immediately get the exclusive agency rights for this drug in Europe!"

"Otherwise, if we really wait for Qingshan Pharmaceutical's clinical data to come out before discussing it, I'm worried that other pharmaceutical companies will get there first!"

At this point, President William frowned slightly for the first time on his relaxed face:

"You also know that we have made a lot of profits over the years by cooperating with Qingshan Pharmaceutical and acting as agents for several of their drugs!"

"Now, not only German BI companies have begun to actively get close to Tsingshan Pharmaceutical, but even Roche and Bayer are said to be interested in currying favor with Tsingshan Pharmaceutical."

"After all, the drugs developed by Qingshan Pharmaceutical are very competitive, and there are almost no competitors in the market! As long as you get their exclusive agency, it's almost like making money without doing anything!"

"They are very jealous!"

Lucas was startled and immediately understood President William's concerns.

No wonder President William, who has always been conservative, suddenly became so radical!
Thinking of this, he nodded hurriedly:
"Boss, I understand. I'll book a flight to China right away. I haven't visited Mr. Zhang Yang in China for a long time!"

"Ok!"

President William showed a smile on his face.

Seeing Lucas took out his phone and prepared to book a flight after receiving the order, William was stunned and hurriedly reminded:
"Lucas, are you planning to go directly to see Zhang Yang like this?"

"Ok?"

Lucas was stunned.

"if not?!"

William shook his head, then stood up from the sofa and walked to the desk.

He opened the drawer and carefully took out a painting.

Lucas also stood up in surprise, his eyes fixed on the painting which looked quite old at first glance.

"Lucas, this is a painting that was previously collected in the British Museum. It's called 'Northern Qi Dynasty Book Reviewing Picture'. It's an important cultural relic from China!"

"I asked you before whether Zhang Yang of Qingshan Pharmaceutical had any special hobbies... Apparently, he already has enough wealth, and money has almost no appeal to him!"

"So, a few days ago, a friend of mine happened to get this painting hidden in the museum through special channels, so I paid to buy it. Zhang doesn't like money, but maybe he will like these important cultural relics?"

"After all, they all seem to have a special affection for these cultural relics lost overseas. Yes, they call them national treasures lost overseas!"

"When you go to China this time, give this painting to Zhang. If he likes it, we can collect more Chinese cultural relics for him."

William didn't finish the last sentence, but Lucas understood the implication.

President William just wants to find Zhang Yang's weakness, and then use the weakness to please Zhang Yang and maintain the cooperative relationship between Qingshan Pharmaceutical and GlaxoSmithKline!
only……

This ancient scroll in front of you seems too precious, right?
"Mr. President, can I ask you something? How much does this 'Northern Qi Dynasty Book Reviewing Map' you mentioned cost?"

"how much is it?"

President William suddenly smiled:
"Lucas, you are too vulgar. This is a cultural relic and cannot be measured by money."

"Of course, if I have to give a price... it's about 900 million pounds. If converted into their currency... it's about million yuan!"

"One hundred million yuan!"

"Isn't this too expensive?!"

However, Lucas didn't say the last word.

If you think about it carefully, compared with the billions of pounds of profits that can be obtained every year from cooperating with Tsingshan Pharmaceutical, what is a mere 900 million pounds gift?
"President, I will personally give this cultural relic to Zhang Yang. He will definitely like it!"

"Well, I hope he likes it. There are still many collections in the British Empire Museum!"

(End of this chapter)